Artificial intelligence is rapidly reshaping eye care. Companies like Alcon, Topcon, Optos, EssilorLuxottica, and Warby Parker are investing in AI technologies to improve diagnostics and patient experiences, while raising questions about their long-term impact on care standards and the U.S. healthcare system.
NEGATIVES?
Overview
POSITIVES?
IMPACT ON HEALTHCARE SYSTEM?
BACK
Next
OVERVIEW
Artificial intelligence is advancing rapidly and will soon aid eye doctors and surgeons in diagnosing eye diseases earlier, personalizing treatments, performing more precise surgeries, and speeding up research.
POSITIVES
NEGATIVES
- Earlier and More Accurate Disease Detection - More Personalized Patient Treatment - Better Monitoring and disease Prediction - More Efficient Use of HealthCare Resources
- Data Privacy Exposure Risks - Dependency on AI - Patient comfortability and trust in AI - Ethical and Societal Risks
IMPACT ON U.S. HEALTHCARE
- Early Disease Detection which plays into managed care - Improved Access to Care (Remote, AI-powered diagnostic, tools, allow, screening, in primary, care, settings or, rural, areas, facilitating faster referrals to specialists) - It may make patients avoid getting yearly eye exams or checkups if AI is involved, which can cause an increase in eye and overall health issues.
Next
BACK
SOURCES
Charters, Lynda. "How AI Is Reshaping Ophthalmology in 2025 and Beyond." Ophthalmology Times, 23 Dec. 2025, www.ophthalmologytimes.com/view/how-ai-is-reshaping-ophthalmology-in-2025-and-beyond. Williams, A. Sydney. "Understand Your Glaucoma Diagnosis." Glaucoma Research Foundation, 18 June 2024, glaucoma.org/articles/understand-your-glaucoma-diagnosis. Li, Zhongwen, et al. "Artificial Intelligence in Ophthalmology: The Path to the Real-World Clinic." Cell Reports Medicine, vol. 4, no. 7, 28 June 2023, p. 101095,
AI Meets Eye Care: A New Vision for
Brendan Buissereth
Created on March 1, 2026
Start designing with a free template
Discover more than 1500 professional designs like these:
View
Scratch and Win
View
The Fortune Ball
View
Movie Classics in Emojis
View
Movie Minigames
View
Snakes and Ladders
View
Guess the Movies with Emojis
View
Hand Drawn Game Board
Explore all templates
Transcript
AI Meets Eye Care: A New Vision for
U.S HEALTH CARE
Start
Artificial intelligence is rapidly reshaping eye care. Companies like Alcon, Topcon, Optos, EssilorLuxottica, and Warby Parker are investing in AI technologies to improve diagnostics and patient experiences, while raising questions about their long-term impact on care standards and the U.S. healthcare system.
NEGATIVES?
Overview
POSITIVES?
IMPACT ON HEALTHCARE SYSTEM?
BACK
Next
OVERVIEW
Artificial intelligence is advancing rapidly and will soon aid eye doctors and surgeons in diagnosing eye diseases earlier, personalizing treatments, performing more precise surgeries, and speeding up research.
POSITIVES
NEGATIVES
- Earlier and More Accurate Disease Detection - More Personalized Patient Treatment - Better Monitoring and disease Prediction - More Efficient Use of HealthCare Resources
- Data Privacy Exposure Risks - Dependency on AI - Patient comfortability and trust in AI - Ethical and Societal Risks
IMPACT ON U.S. HEALTHCARE
- Early Disease Detection which plays into managed care - Improved Access to Care (Remote, AI-powered diagnostic, tools, allow, screening, in primary, care, settings or, rural, areas, facilitating faster referrals to specialists) - It may make patients avoid getting yearly eye exams or checkups if AI is involved, which can cause an increase in eye and overall health issues.
Next
BACK
SOURCES
Charters, Lynda. "How AI Is Reshaping Ophthalmology in 2025 and Beyond." Ophthalmology Times, 23 Dec. 2025, www.ophthalmologytimes.com/view/how-ai-is-reshaping-ophthalmology-in-2025-and-beyond. Williams, A. Sydney. "Understand Your Glaucoma Diagnosis." Glaucoma Research Foundation, 18 June 2024, glaucoma.org/articles/understand-your-glaucoma-diagnosis. Li, Zhongwen, et al. "Artificial Intelligence in Ophthalmology: The Path to the Real-World Clinic." Cell Reports Medicine, vol. 4, no. 7, 28 June 2023, p. 101095,
BACK